Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Iteos Therapeutics, Inc. (ITOS)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 37,960,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,000 5,000
Total Buy Value $0 $0 $41,850 $41,850
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 350,000 379,615
Total Sell Value $0 $0 $5,692,673 $6,289,886
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 3
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 227
  Page 3 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Detheux Michel Chief Executive Officer   •       –      –    2021-12-21 4 OE $4.30 $82,672 D/D 19,226 97,426     -
   Hallal David Director   –       •      –    2021-12-20 4 S $43.57 $2,178,500 D/D (50,000) 0     -
   Hallal David Director   –       •      –    2021-12-20 4 OE $2.95 $174,500 D/D 50,000 50,000     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-12-20 4 AS $43.94 $400,337 D/D (9,111) 78,200     -
   Detheux Michel Chief Executive Officer   •       –      –    2021-12-20 4 OE $4.30 $39,177 D/D 9,111 87,311     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2021-12-17 4 AS $41.00 $287,000 D/D (7,000) 0     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2021-12-17 4 OE $4.30 $30,100 D/D 7,000 7,000     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2021-12-10 4 AS $34.50 $120,750 D/D (3,500) 0     -
   Lager Joanne Jenkins Chief Medical Officer   •       –      –    2021-12-10 4 OE $4.30 $15,050 D/D 3,500 3,500     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-12-07 4 AS $33.15 $646,401 I/I (19,456) 2,885,470     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-12-07 4 AS $33.15 $1,081,697 I/I (32,558) 4,730,197     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-12-07 4 AS $33.15 $646,401 I/I (19,456) 2,885,470     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-12-06 4 AS $32.35 $332,698 I/I (10,208) 2,904,926     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-12-06 4 AS $32.35 $556,766 I/I (17,083) 4,762,755     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-12-06 4 AS $32.35 $332,698 I/I (10,208) 2,904,926     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-12-03 4 AS $34.68 $701,513 I/I (20,167) 2,915,134     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-12-03 4 AS $34.68 $1,173,965 I/I (33,749) 4,779,838     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-12-03 4 AS $34.68 $701,513 I/I (20,167) 2,915,134     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-12-02 4 AS $33.74 $1,262,788 I/I (37,187) 2,935,301     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-12-01 4 AS $33.82 $424,872 I/I (12,395) 2,972,488     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-11-30 4 AS $34.62 $1,190,902 I/I (33,937) 2,984,883     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-11-29 4 AS $34.46 $357,656 I/I (10,371) 3,018,820     -
   Mpm Bioventures 2018 Gp Llc 10% Owner   –       –       •   2021-11-29 4 AS $34.46 $357,656 I/I (10,371) 3,018,820     -
   Oncology Impact Fund (cayman) Management L.p. 10% Owner   –       –       •   2021-11-29 4 AS $34.46 $598,543 I/I (17,356) 4,953,360     -
   Mpm Asset Management Investors Bv2018 Llc 10% Owner   –       –       •   2021-11-26 4 AS $35.49 $453,110 I/I (12,674) 3,029,191     -
  227 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us